GenMark Diagnostics - 8 Year Stock Price History | GNMK

Historical daily share price chart and data for GenMark Diagnostics since 2010 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for GenMark Diagnostics as of December 07, 2018 is 5.03.
GenMark Diagnostics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 6.1452 4.6500 8.5600 4.0100 5.0300 20.62%
2017 10.3000 12.0200 13.4500 3.8100 4.1700 -65.93%
2016 8.5093 7.5500 12.9900 4.6500 12.2400 57.73%
2015 9.9861 13.8700 13.8700 6.3600 7.7600 -42.98%
2014 11.1885 13.2200 14.0500 8.6700 13.6100 2.41%
2013 11.9106 9.4800 15.5500 9.0000 13.2900 47.67%
2012 6.1362 4.3800 9.9500 3.7900 9.0000 118.45%
2011 4.9874 4.6900 6.2500 3.6200 4.1200 0.73%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.281B $0.053B
GenMark Diagnostics, Inc. is a molecular diagnostics company focused on developing and commercializing its proprietary eSensor(R) detection technology. The eSensor? XT-8 system is the second generation in GenMark Dx's eSensor? platform, utilizing electrochemical detection technology to detect nucleic acids on a microarray. The XT-8 System enables multiplex detection of DNA and RNA targets. The Company has developed four diagnostic tests for use with its XT-8 System. Its Cystic Fibrosis Genotyping Test, which detects pre-conception risks of cystic fibrosis, and its Warfarin Sensitivity Test, which determines an individual's ability to metabolize the oral anticoagulant warfarin, have received FDA clearance. It has also developed a Respiratory Viral Panel Test, which detects the presence of major respiratory viruses, and a Thrombosis Risk Test, which detects an individual's increased risk of blood clots. GenMark Diagnostics, Inc. is based in Pasadena, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $94.952B 22.13
Intuitive Surgical (ISRG) United States $56.151B 55.25
Edwards Lifesciences (EW) United States $32.865B 35.17
Fresenius Medical Care AG KGaA (FMS) Germany $21.890B 14.80
IDEXX Laboratories (IDXX) United States $16.385B 46.80
ABIOMED (ABMD) United States $14.301B 102.76
Hologic (HOLX) United States $12.141B 18.74
Teleflex (TFX) United States $11.801B 26.79
Varian Medical Systems (VAR) United States $10.826B 26.94
DexCom (DXCM) United States $10.787B 0.00
STERIS (STE) United Kingdom $9.628B 25.55
Masimo (MASI) United States $5.580B 36.19
LivaNova (LIVN) United Kingdom $4.617B 29.64
Penumbra (PEN) United States $4.545B 274.42
Globus Medical (GMED) United States $4.509B 28.26
Integra LifeSciences Holdings (IART) United States $4.256B 20.73
Cantel Medical (CMD) United States $3.351B 33.05
Wright Medical Group (WMGI) Netherlands $3.313B 0.00
Inogen (INGN) United States $2.966B 64.02
Integer Holdings (ITGR) United States $2.712B 22.70
Glaukos (GKOS) United States $2.247B 0.00
Halyard Health (AVNS) United States $2.186B 19.70
Tandem Diabetes Care (TNDM) United States $1.921B 0.00
OPKO Health (OPK) United States $1.836B 0.00
Mazor Robotics (MZOR) Israel $1.532B 0.00
Luminex (LMNX) United States $1.267B 45.84
Nevro (NVRO) United States $1.250B 0.00
AxoGen (AXGN) United States $1.137B 0.00
Natus Medical (BABY) United States $1.133B 23.79
Pacific Biosciences Of California (PACB) United States $1.121B 0.00
Orthofix (OFIX) United States $1.066B 30.78
CryoLife (CRY) United States $1.057B 92.19
Tactile Systems Technology (TCMD) United States $0.988B 157.38
Intersect ENT (XENT) United States $0.940B 0.00
Mesa Laboratories (MLAB) United States $0.815B 48.19
AngioDynamics (ANGO) United States $0.771B 26.99
Accelerate Diagnostics (AXDX) United States $0.767B 0.00
ViewRay (VRAY) United States $0.603B 0.00
SI-BONE INC (SIBN) United States $0.494B 0.00
Sientra (SIEN) United States $0.493B 0.00
Veracyte (VCYT) United States $0.483B 0.00
OrthoPediatrics (KIDS) United States $0.424B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.395B 0.00
Quotient (QTNT) Switzerland $0.361B 0.00
Neuronetics (STIM) United States $0.346B 0.00
Accuray (ARAY) United States $0.334B 0.00
SeaSpine Holdings (SPNE) United States $0.319B 0.00
Nuvectra (NVTR) United States $0.316B 0.00
Fluidigm (FLDM) United States $0.309B 0.00
IRadimed (IRMD) United States $0.278B 72.57
RTI Surgical (RTIX) United States $0.242B 38.20
Helius Medical Technologies (HSDT) United States $0.234B 0.00
Pulse Biosciences (PLSE) United States $0.219B 0.00
T2 Biosystems (TTOO) United States $0.184B 0.00
Ra Medical Systems (RMED) United States $0.115B 0.00
Alphatec Holdings (ATEC) United States $0.113B 0.00
Ekso Bionics Holdings (EKSO) United States $0.111B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.094B 0.00
Sensus Healthcare (SRTS) United States $0.089B 0.00
Apollo Endosurgery (APEN) United States $0.088B 0.00
Second Sight Medical Products (EYES) United States $0.077B 0.00
EDAP TMS (EDAP) France $0.075B 0.00
Biosig Technologies (BSGM) United States $0.065B 0.00
Restoration Robotics (HAIR) United States $0.045B 0.00
Viveve Medical (VIVE) United States $0.043B 0.00
OBALON THERPTCS (OBLN) United States $0.041B 0.00
Vermillion (VRML) United States $0.039B 0.00
ConforMIS (CFMS) United States $0.032B 0.00
Lianluo Smart (LLIT) China $0.028B 0.00
PAVmed (PAVM) United States $0.027B 0.00
Titan Medical (TMDI) Canada $0.025B 0.00
Dynatronics (DYNT) United States $0.021B 0.00
DarioHealth (DRIO) Israel $0.020B 0.00
Neovasc (NVCN) Canada $0.018B 0.00
Nanovibronix (NAOV) United States $0.015B 0.00
Bioanalytical Systems (BASI) United States $0.013B 0.00
ENDRA Life Sciences (NDRA) United States $0.012B 0.00
Presbia (LENS) Ireland $0.011B 0.00
Allied Healthcare Products (AHPI) United States $0.008B 0.00
Avinger (AVGR) United States $0.008B 0.00
Atossa Genetics (ATOS) United States $0.007B 0.00
ReWalk Robotics (RWLK) Israel $0.007B 0.00
Cesca Therapeutics (KOOL) United States $0.007B 0.00
Microbot Medical (MBOT) United States $0.006B 0.00
Sunshine Heart Inc (CHFS) United States $0.006B 0.00
Amedica (SINT) United States $0.005B 0.00
EnteroMedics (RSLS) United States $0.001B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00